SCHEMBL27406221

SCHEMBL27406221

COc1ccccc1CNC(=O)CSc1nc(=O)[nH]cc1C

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ RAB9A P51151 3/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ HPGD P15428 2/20 0.59
▸ PKM P14618 2/20 0.59
▸ POLB P06746 1/20 0.59
▸ ALDH1A1 P00352 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ KMT2A Q03164 2/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27405870 0.82 MEN1 (0.46) MAPTNPC1ALDH1A1KDM4EKMT2A
SCHEMBL27405874 0.82 LMNA (0.50) MAPTSMN1; SMN2HPGDPOLBALDH1A1
SCHEMBL27405477 0.82 LMNA (0.60) SMN1; SMN2HPGDALDH1A1KDM4EKMT2A
SCHEMBL27405479 0.81 TDP1 (0.58) MAPTSMN1; SMN2RAB9APOLBALDH1A1
SCHEMBL27405594 0.79 RXFP1 (0.60) MAPTSMN1; SMN2POLBALDH1A1KDM4E
SCHEMBL27406004 0.78 LMNA (0.40) MAPTSMN1; SMN2RAB9APKMPOLB
SCHEMBL27406002 0.77 ALDH1A1 (0.42) MAPTSMN1; SMN2POLBALDH1A1KDM4E
SCHEMBL27406001 0.77 LMNA (0.48) SMN1; SMN2POLBALDH1A1KMT2ATDP1
SCHEMBL27398877 0.77 ALDH1A1 (0.45) MAPTALDH1A1KDM4EKMT2ATDP1
SCHEMBL27406110 0.77 LMNA (0.56) SMN1; SMN2POLBALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112918-A1 RNA DEGRADERS AND USES THEREOF ARRAKIS THERAPEUTICS, INC. (US) 2024-05-30 — — WO disclosed
Send feedback